PTC Therapeutics
PTCT
PTCT
174 hedge funds and large institutions have $2.21B invested in PTC Therapeutics in 2019 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 77 increasing their positions, 36 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
12% more call options, than puts
Call options by funds: $10M | Put options by funds: $8.99M
6% more funds holding
Funds holding: 164 → 174 (+10)
3.72% more ownership
Funds ownership: 96.65% → 100.37% (+3.7%)
Holders
174
Holding in Top 10
7
Calls
$10M
Puts
$8.99M
Top Buyers
| 1 | +$54.2M | |
| 2 | +$53.4M | |
| 3 | +$40.9M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$29.1M |
| 5 |
RI
RTW Investments
New York
|
+$22.3M |
Top Sellers
| 1 | -$43.5M | |
| 2 | -$13.8M | |
| 3 | -$13M | |
| 4 |
PP
PDT Partners
New York
|
-$9.53M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.71M |